MAY 20, 2018 3:15 PM PDT

Gene Found to Help Prevent Brain Disease

WRITTEN BY: Carmen Leitch

It’s known that disorders like Alzheimer's and Parkinson's are related to the buildup of aberrant proteins in the brain. While the exact source of such proteins is unknown, it's known that errors in the cell’s ability to translate the genetic code into the right protein can cause faulty proteins to accumulate. The subject has been under study in the lab of University of California San Diego Professor Susan Ackerman for over a decade. Now, she and colleagues have found that a gene called Ankrd16 can stop the aggregation of aberrant proteins.

Image reveals Purkinje cells (gray) and their dendrites, as well as an accumulation of protein deposits (red dots). / Credit: Ackerman Lab/UC San Diego

The genetic code is translated into an intermediary molecule, called RNA, and then transcribed into protein. Usually, proofreading mechanisms do a kind of quality control on the sequences to prevent errors from being introduced. Publishing in Nature, a research team including Ackerman, Paul Schimmel and My-Nuong Vo of the Scripps Research Institute and Markus Terrey of UC San Diego have reported that Ankrd16 rescues certain kinds of neuronal cells that die when the proofreading isn't working. 

Those neuronal cells, Purkinje cells of the cerebellum, activate serine (an amino acid) improperly when they lack Ankrd16. That dysfunctional serine is then added to new proteins, which leads to a buildup.

"Simplified, you may think of Ankrd16 as acting like a sponge or a 'failsafe' that captures incorrectly activated serine and prevents this amino acid from being improperly incorporated into proteins, which is particularly helpful when the ability of nerve cells to proofread and correct mistakes declines," explained Ackerman, the Stephen W. Kuffler Chair in Biology, who has positions with the UC San Diego School of Medicine and the Howard Hughes Medical Institute.

Proofreading defect bypassed. / Credit: Ackerman Lab/UC San Diego

Purkinje cells normally have low levels of Ankrd16 anyway, so they are particularly susceptible to defects in proofreading. Raising Ankrd16 levels protected the cells from Purkinje cells from death, the researchers found. When Ankrd16 was deleted from other kinds of neurons in mice that did not proofread properly, there was a widespread accumulation of dysfunctional proteins.

Ankrd16 has thus been suggested as a part of the machinery that stops major diseases from happening when proofreading isn’t working as it should. Because there have not been many candidates for genes that are responsible for the protein defects in neurodegeneration, the scientists think that this work may present a promising new drug target.

Learn more about the role of aberrant proteins in neurodegenerative diseases from the video.

 

Sources: AAAS/Eurekalert! Via University of California, San Diego, Nature

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 09, 2019
Genetics & Genomics
DEC 09, 2019
Researchers Rewire E. coli to Consume Carbon Dioxide
Milo et. al.   Researchers have genetically rewired the metabolism of Escherichia coli to be autotrophic, using formate (COOH) as a food sou...
JAN 02, 2020
Genetics & Genomics
JAN 02, 2020
Mysterious Extrachromosomal DNA is Linked to Childhood Cancer
Scientists are learning more about an unusual kind of DNA that's separate from a cell's genomic DNA....
JAN 19, 2020
Neuroscience
JAN 19, 2020
New Proteins Found in the Optical Processing of Lazy Eyes
Ophthalmology – Amblyopia: By Christine Law M.D.   Researchers in the Bear Lab at the Massachusetts Institute of Technology found surprising con...
JAN 19, 2020
Immunology
JAN 19, 2020
Overactive Immune Gene May Cause Schizophrenia
A windy road links excessive activity of the “C4” gene to the development of schizophrenia. Researchers begin to study C4 activity as part of n...
FEB 05, 2020
Clinical & Molecular DX
FEB 05, 2020
A new CRISPR-based test for coronavirus infections
A surge in infections has caused panic surrounding the coronavirus (2019-nCoV) outbreak to reach a fever pitch. Despite being only moderately infective, 20...
FEB 22, 2020
Genetics & Genomics
FEB 22, 2020
Evidence of Resistance to White-Nose Syndrome Appears in Some Bats
A small new study suggests that some bats might be able to resist a devastating fungal disease called white nose syndrome that has destroyed many bat populations....
Loading Comments...